Abstract |
We investigated the effect of 2-methyl-arachidonyl-2'-fluoro-ethylamide ( Met-F-AEA), a stable analog of the endocannabinoid anandamide, on a rat thyroid epithelial cell line (FRTL-5) transformed by the K-ras oncogene, and on epithelial tumors derived from these cells. Met-F-AEA effect in vivo was evaluated in a nude mouse xenograft model, where K-ras-transformed (KiMol) cells were implanted subcutaneously. Met-F-AEA (0.5 mg/kg/dose) induced a drastic reduction in tumor volume. This effect was inhibited by the CB1 receptor antagonist SR141716A (0.7 mg/kg/dose) and was accompanied by a strong reduction of K-ras activity. Accordingly, KiMol cells and tumors express CB1 receptors. Met-F-AEA inhibited (IC50 ~5 mM) the proliferation in vitro and the transition to the S phase of KiMol cells and it reduced K-ras activity; these effects were antagonized by SR141716A. Met-F-AEA cytostatic action was significantly smaller in nontransformed FRTL-5 cells than in KiMol cells. Met-F-AEA treatment exerted opposite effects on the expression of CB1 receptors in KiMol and FRTL-5 cells, with a strong up-regulation in the former case and a suppression in nontransformed cells. The data suggest that: 1) Met-F-AEA inhibits ras oncogene-dependent tumor growth in vivo through CB1 cannabinoid receptors; and 2) responsiveness of FRTL-5 cells to endocannabinoids depends on whether or not they are transformed by K-ras.
|
Authors | M Bifulco, C Laezza, G Portella, M Vitale, P Orlando, L De Petrocellis, V Di Marzo |
Journal | FASEB journal : official publication of the Federation of American Societies for Experimental Biology
(FASEB J)
Vol. 15
Issue 14
Pg. 2745-7
(Dec 2001)
ISSN: 1530-6860 [Electronic] United States |
PMID | 11687506
(Publication Type: Journal Article)
|
Chemical References |
- 2-methylarachidonyl-2'-fluoroethylamide
- Arachidonic Acids
- Cannabinoid Receptor Modulators
- Cannabinoids
- Endocannabinoids
- Piperidines
- Polyunsaturated Alkamides
- Pyrazoles
- RNA, Messenger
- Receptors, Cannabinoid
- Receptors, Drug
- Rimonabant
- anandamide
|
Topics |
- Animals
- Arachidonic Acids
(chemistry, pharmacology)
- Blotting, Western
- Cannabinoid Receptor Modulators
- Cannabinoids
(metabolism, pharmacology)
- Cell Cycle
(drug effects)
- Cell Division
(drug effects)
- Cell Line
- Cell Line, Transformed
- Dose-Response Relationship, Drug
- Endocannabinoids
- Genes, ras
(genetics, physiology)
- Mice
- Mice, Nude
- Neoplasms, Experimental
(pathology, prevention & control)
- Piperidines
(pharmacology)
- Polyunsaturated Alkamides
- Pyrazoles
(pharmacology)
- RNA, Messenger
(drug effects, genetics, metabolism)
- Rats
- Receptors, Cannabinoid
- Receptors, Drug
(antagonists & inhibitors, genetics, metabolism)
- Rimonabant
- Thyroid Neoplasms
(pathology, prevention & control)
- Xenograft Model Antitumor Assays
|